(Fighting against New Coronary Pneumonia) Trump: Hope to complete R & D of New Crown Vaccine by the end of 2020
China News Service, Washington, May 15 (Reporter Chen Mengtong) US President Trump announced a public-private partnership program aimed at accelerating the development of a new coronavirus vaccine at the White House on the 15th, and "hopes to complete it by the end of 2020."
Data graph: US President Trump at an epidemic news conference.
Trump announced the vaccine research and development plan called "Curve Acceleration" at the press conference held in the Rose Garden that day, and made the above statement.
Trump said the two keys to reopening the U.S. economy are virus testing and vaccine development. At present, the average daily testing volume in the United States is nearly 350,000. "When we are talking about developing treatments and vaccines as soon as possible, we hope to complete them by the end of this year."
He said that the United States is screening a set of potentially effective vaccines from 14 R & D-stage vaccines for clinical trials.
Trump also revealed that the United States has started vaccine research and development work on January 11. The National Institutes of Health started the work a few hours after the new coronavirus gene sequence was announced.
The National Institutes of Health announced on March 16 that a new coronavirus vaccine developed in the United States has entered the first phase of clinical trials.
Fuch, director of the National Institute of Allergy and Infectious Diseases, has previously stated that even if the initial safety trials of the vaccine are progressing well, it will take a year to a year and a half from its large-scale application. He wore a mask to accompany Trump to the press conference that day, without speaking or answering questions.
At the press conference, U.S. Secretary of Health and Human Services Aza said at the press conference that the goal of the United States was to develop a vaccine by January 2021. At that time, the federal government will release the vaccination through "emergency use authorization" and other means.
According to data from Johns Hopkins University in the United States, as of 7 pm on the 15th, the number of confirmed cases of new coronary pneumonia in the United States reached 1.442 million, and 87,493 people died. (Finish)